Cuban American National Foundation

Ahold Delhaize announces the nomination of a new member to its Supervisory Board

Retrieved on: 
Tuesday, February 28, 2023
Extra Space Storage, Hyatt, Supervisory board, Ahold Delhaize, Annual, Senior, NYSE, EXR, Julia, Digital newspaper technology, Cuban American National Foundation, Restaurant, AGM, Digital, Supervision, Delhaize Group, EVP, Communication, Volvo, Management

Zaandam, the Netherlands, February 28, 2023 – Ahold Delhaize today announces the nomination of Julia Vander Ploeg for appointment to Ahold Delhaize’s Supervisory Board.

Key Points: 
  • Zaandam, the Netherlands, February 28, 2023 – Ahold Delhaize today announces the nomination of Julia Vander Ploeg for appointment to Ahold Delhaize’s Supervisory Board.
  • The Supervisory Board will propose the appointment to the Annual General Meeting (AGM) of Shareholders on April 12, 2023.
  • Peter Agnefjäll, Chair of the Supervisory Board: “We are delighted to propose Julia Vander Ploeg for appointment to the Supervisory Board.
  • Peter Agnefjäll: “We would like to thank Bala for his valuable contributions over the past two years to Ahold Delhaize.

Brookfield Reinsurance Records $128 Million of Net Income and Announces Regular Distribution

Retrieved on: 
Thursday, May 12, 2022
100,000, Income, Depreciation, XXV, Disclosure, News, Investment, Goal, Mission statement, Insurance, Contract, Government, Advertising, Health, IASB, Nature, XV, COVID-19, Failure, Legislation, Method, Forward-looking statement, Communication, Safety, Pacific typhoon season, Earthquake, Cuban American National Foundation, IFRS, Behavior, Maintenance, Private Securities Litigation Reform Act, Prospectus, Achievement, Bank, Risk management

Excess Capital is the amount of capital in the business that is not currently supporting insurance contracts within regulated insurance entities.

Key Points: 
  • Excess Capital is the amount of capital in the business that is not currently supporting insurance contracts within regulated insurance entities.
  • Net Reserve Capital is the capital within regulated entities that is currently supporting insurance contracts.
  • We use Net Reserve Capital to assess our return on our equity supporting insurance contracts.
  • Certain of the information contained herein is based on or derived from information provided by independent third-party sources.

Castellum, Inc. Announces Appointment of Former Congressman and NBA Player Tom McMillen to Company's Advisory Board

Retrieved on: 
Thursday, February 3, 2022
Fitness, CEO, Government, Information warfare, University, McMillen, Physical fitness, Ethics, Member of Congress, House, Securities Act of 1933, Nutrition, History of the University of Maryland, College Park, Cuban American National Foundation, Connecticut Board of Regents for Higher Education, Computer security, Company, Software development, Founding, Louisiana House of Representatives, GLOBE, Representative, NBA, Association, Letter, Securities Exchange Act of 1934, Information technology, Powers of the President of Singapore, OTC, Software engineering, Review, Advisory board, Management, Castellum, Bound, Sport, Olympian

POTOMAC, Md., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) proudly announces that former Congressman, NBA player, Olympian, and Rhodes Scholar Tom McMillen joined the Company's Advisory Board.

Key Points: 
  • POTOMAC, Md., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) proudly announces that former Congressman, NBA player, Olympian, and Rhodes Scholar Tom McMillen joined the Company's Advisory Board.
  • "We are thrilled to announce that Tom McMillen has joined our advisory board," said Mark Fuller, President and CEO of Castellum .
  • "Tom brings a great combination of public company experience, government expertise, strong intellect, financial savvy, and general business insight to Castellum.
  • During his career, McMillen has been an active investor, principal, and board member in many companies, including ten public companies.

Brookfield Reinsurance Announces Third Quarter Results, Regular Distribution and Appointment of Directors

Retrieved on: 
Thursday, November 11, 2021
Mission statement, Legislation, Safety, 100,000, Achievement, Maintenance, Private Securities Litigation Reform Act, News, Contract, Earthquake, Behavior, Government, Health, Prospectus, Method, Pacific typhoon season, Failure, IASB, Insurance, Income, Investment, Depreciation, Goal, COVID-19, IFRS, Forward-looking statement, Advertising, XXV, Disclosure, Nature, Cuban American National Foundation, XV, Communication, FFO, Audit, Risk management

We define FFO as net income excluding the impact of depreciation and amortization, deferred income taxes, income from equity accounted investments, breakage and transaction costs.

Key Points: 
  • We define FFO as net income excluding the impact of depreciation and amortization, deferred income taxes, income from equity accounted investments, breakage and transaction costs.
  • FFO is a measure of operating performance We use FFO to assess our operating results.
  • Excess Capital is the amount of capital in the business that is not currently supporting insurance contracts within regulated insurance entities.
  • Certain of the information contained herein is based on or derived from information provided by independent third-party sources.

Brookfield Appoints Michael McRaith Vice Chairman of Insurance Solutions Business

Retrieved on: 
Thursday, October 28, 2021
Safety, 100,000, Method, Cuban American National Foundation, Goal, XXV, Behavior, Failure, Insurance, Private Securities Litigation Reform Act, Achievement, Government, Nature, Forward-looking statement, Maintenance, Investment, Disclosure, XV, COVID-19, Pacific typhoon season, News, Health, Earthquake, Legislation, Audit, Risk management

Particularly, statements about Brookfield Reinsurances agreement to acquire American National, its agreement to reinsure additional future liabilities under its reinsurance arrangement AEILIC and its agreement to acquire the additional equity interest in AEL are forward-looking statements.

Key Points: 
  • Particularly, statements about Brookfield Reinsurances agreement to acquire American National, its agreement to reinsure additional future liabilities under its reinsurance arrangement AEILIC and its agreement to acquire the additional equity interest in AEL are forward-looking statements.
  • We caution that the foregoing list of important factors that may affect future results is not exhaustive and other factors could also adversely affect its results.
  • Past performance is not indicative nor a guarantee of future results.
  • Certain of the information contained herein is based on or derived from information provided by independent third-party sources.

Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board

Retrieved on: 
Thursday, August 5, 2021
Health, Medical Devices, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Transfer, Company, Chief executive officer, International Life Sciences Institute, Founder, Communications and Information Technology Commission (Saudi Arabia), U.S. Securities and Exchange Commission, United, Industry, Tel Aviv Stock Exchange, Psoriasis, Technology, Hepatocellular carcinoma, Fatty liver disease, Melanoma, Writing, Cuban American National Foundation, Risk, General manager, Bristol Myers Squibb, Digital health, Cancer, Erectile dysfunction, Patient, COVID-19, Hong Kong International Medical Devices and Supplies Fair, The Co Founder, SEC, Liver cancer, Nash, New York Stock Exchange, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Prostate, HCC, Robotics, Drug development, Liver, Colon, Food, Nasdaq, Forward-looking statement, Pharmaceutical industry

During the past 35 years, Mr. Yossi Bornstein has played key roles in the Israeli biomed industry.

Key Points: 
  • During the past 35 years, Mr. Yossi Bornstein has played key roles in the Israeli biomed industry.
  • Mr. Bornstein is the CEO and the founder of Shizim group, a life science holding company.
  • Mr. Bornstein is the founder of ILSI - Israel Life Science Industry Organization and Founder of ITTN - Israel Tech Transfer Organization.
  • We welcome Yossi Borenstein as an External Director and trust that his skills will be highly valuable for Can-Fite, stated Can-Fite CEO Pnina Fishman.

Can-Fite Reports First Quarter 2021 Financial Results & Provides Clinical Update

Retrieved on: 
Thursday, May 27, 2021
General Health, Professional services, Health, Finance, New York Stock Exchange, Tel Aviv Stock Exchange, Cuban American National Foundation, Cash and cash equivalents, Money, Economy, Service companies

(NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended March 31, 2021.

Key Points: 
  • (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended March 31, 2021.
  • The Company expects to complete enrollment in Q3 2021 and report topline results in Q4 2021.
  • The decrease in financial expense, net was mainly due to finance income recorded from revaluation of our short-term investment.
  • As of March 31, 2021, Can-Fite had cash and cash equivalents and short term deposits of $11.24 million as compared to $8.26 million at December 31, 2020.

Jorge Mas and family make $5 million lead gift to CasaCuba at FIU

Retrieved on: 
Wednesday, May 19, 2021
Opposition to Fidel Castro, Cuba–United States relations, Jorge Mas Canosa, Jorge Mas, Cuban American National Foundation, Canosa, Mas, Foreign relations of the United States, Anti-communism, Politics

"We thank the Mas family, who for decades have supported the dreams of Cuban Americans across our nation, for helping CasaCuba become a reality.

Key Points: 
  • "We thank the Mas family, who for decades have supported the dreams of Cuban Americans across our nation, for helping CasaCuba become a reality.
  • Jorge Mas Canosa, the Mas family patriarch, founded the Cuban American National Foundation (CANF) in 1981 with a group of fellow Cuban exiles.
  • Rootedin the belief that education is the cornerstone of society, the Mas family established in 1996 the Mas Family Scholarships.
  • Today the Mas Family Scholarships have supported the education of over 300 students in the most prestigious universities.\n"We are profoundly grateful to Jorge Mas and the entire Mas family for their historic gift to CasaCuba," said Mara Carla Chicun, founding executive director of CasaCuba.

Can-Fite to Present at Benzinga’s Global Small Cap Conference on May 13, 2021

Retrieved on: 
Thursday, May 6, 2021
Oncology, Health, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Cuba–United States relations, Opposition to Fidel Castro, Fite, Tase, Tel Aviv Stock Exchange, Cuban American National Foundation, Pnina, Forward-looking statement, Fishman, Articles, Foreign relations of the United States

(NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company\xe2\x80\x99s CEO Dr. Pnina Fishman will present at Benzinga\xe2\x80\x99s Global SmallCap Conference on Thursday, May 13, 2021 at 11:10 a.m.

Key Points: 
  • (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the Company\xe2\x80\x99s CEO Dr. Pnina Fishman will present at Benzinga\xe2\x80\x99s Global SmallCap Conference on Thursday, May 13, 2021 at 11:10 a.m.
  • Investors interested in viewing Can-Fite\xe2\x80\x99s presentation may register with free access for the two-day conference which takes place virtually on May 13 and 14, 2021 here: https://www.benzinga.com/events/small-cap/global/\nDr.
  • In addition, from time to time, Can-Fite or its representatives have made or may make forward-looking statements, orally or in writing.
  • Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made.

Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update

Retrieved on: 
Thursday, March 25, 2021
Oncology, Professional services, Health, Finance, Clinical trials, Pharmaceutical, Biotechnology, Service companies, Cuba–United States relations, Opposition to Fidel Castro, Tel Aviv Stock Exchange, Cuban American National Foundation, fis, New York Stock Exchange, Companies, Finance

(NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the year ended December 31, 2020.

Key Points: 
  • (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the year ended December 31, 2020.
  • 2020 was a pivotal year for Can-Fite as we demonstrated a robust clinical proof of concept for both Piclidenoson and Namodenoson, stated Can-Fite CEO Dr. Pnina Fishman.
  • Financial expense, net for the year ended December 31, 2020 aggregated $0.3 million compared to $0.6 million for the year ended December 31, 2019.
  • The decrease in financial expense, net was mainly due to a decrease in the revaluation of our short-term investment.